mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |